Histogen Inc. [NASDAQ: HSTO] stock went on an upward path that rose over 15.04% on Wednesday, amounting to a one-week price increase of more than 6.56%. The company report on March 30, 2021 that Histogen to Present at the 20th Annual Needham Virtual Healthcare Conference.
Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the 20th Annual Needham Virtual Healthcare Conference. The virtual presentation is scheduled for Tuesday, April 13, 2021 at 3:00 p.m. Eastern Time.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Over the last 12 months, HSTO stock dropped by -58.08%. The average equity rating for HSTO stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $47.88 million, with 35.68 million shares outstanding and 30.31 million shares in the current float. Compared to the average trading volume of 4.42M shares, HSTO stock reached a trading volume of 1159932 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Histogen Inc. [HSTO]:
The Average True Range (ATR) for Histogen Inc. is set at 0.15, with the Price to Sales ratio for HSTO stock in the period of the last 12 months amounting to 22.80. The Price to Book ratio for the last quarter was 2.28.
HSTO Stock Performance Analysis:
Histogen Inc. [HSTO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.56. With this latest performance, HSTO shares gained by 11.11% in over the last four-week period, additionally sinking by -16.67% over the last 6 months – not to mention a drop of -58.08% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HSTO stock in for the last two-week period is set at 50.69, with the RSI for the last a single of trading hit 52.13, and the three-weeks RSI is set at 50.26 for Histogen Inc. [HSTO]. The present Moving Average for the last 50 days of trading for this stock 1.3264, while it was recorded at 1.2160 for the last single week of trading, and 1.8866 for the last 200 days.
Insight into Histogen Inc. Fundamentals:
Histogen Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.90 and a Current Ratio set at 3.00.
HSTO Stock EPS
With the latest financial reports released by the company, Histogen Inc. posted -1.4/share EPS, while the average EPS was predicted by analysts to be reported at -1.2/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -16.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HSTO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Histogen Inc. go to 38.00%.
Histogen Inc. [HSTO] Insider Position Details
There are presently around $1 million, or 1.50% of HSTO stock, in the hands of institutional investors. The top three institutional holders of HSTO stocks are: VANGUARD GROUP INC with ownership of 124,300, which is approximately -0.002% of the company’s market cap and around 31.98% of the total institutional ownership; UNITED CAPITAL FINANCIAL ADVISERS, LLC, holding 80,747 shares of the stock with an approximate value of $91000.0 in HSTO stocks shares; and WARBERG ASSET MANAGEMENT LLC, currently with $84000.0 in HSTO stock with ownership of nearly New of the company’s market capitalization.
7 institutional holders increased their position in Histogen Inc. [NASDAQ:HSTO] by around 91,172 shares. Additionally, 8 investors decreased positions by around 150,509 shares, while 8 investors held positions by with 284,939 shares. The mentioned changes placed institutional holdings at 526,620 shares, according to the latest SEC report filing. HSTO stock had 4 new institutional investments in for a total of 86,963 shares, while 3 institutional investors sold positions of 42,312 shares during the same period.